Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Accidents (Phase 1)
Acute Febrile Encephalopathy (Phase 1)
Acute Kidney Injury (Phase 1/Phase 2)
Acute Lung Injury (Phase 1/Phase 2)
Acute-On-Chronic Liver Failure (Phase 2)
Aging (Phase 1/Phase 2)
Alzheimer Disease (Phase 1/Phase 2)
Anemia (Phase 1/Phase 2)
Anemia, Aplastic (Phase 2)
Anemia, Sickle Cell (Phase 2)
Angina Pectoris (Phase 1/Phase 2)
Arthritis, Rheumatoid (Phase 1/Phase 2)
Asthma (Phase 1/Phase 2)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 2)
Basal Ganglia Hemorrhage (Phase 2)
beta-Thalassemia (Phase 2)
Bone Diseases (Phase 1/Phase 2)
Bone Marrow Failure Disorders (Phase 1/Phase 2)
Brain Infarction (Phase 1/Phase 2)
Brain Ischemia (Phase 1)
Bronchial Fistula (Phase 1)
Bronchopulmonary Dysplasia (Phase 1/Phase 2)
Burns (Phase 1/Phase 2)
Cardiomyopathies (Phase 2)
Cardiomyopathy, Dilated (Phase 1/Phase 2)
Cartilage Diseases (Phase 1/Phase 2)
Central Nervous System Diseases (Phase 1/Phase 2)
Cerebral Hemorrhage (Phase 1)
Cerebral Infarction (Phase 1/Phase 2)
Cerebral Palsy (Phase 2)
Cholangitis, Sclerosing (Phase 1/Phase 2)
Chronic Limb-Threatening Ischemia (Phase 2)
Colitis, Ulcerative (Phase 1/Phase 2)
Congenital Abnormalities (Phase 1)
Corneal Diseases (Phase 1)
Coronavirus (Phase 1/Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 3)
Crohn Disease (Phase 1/Phase 2)
Dermatitis ()
Dermatitis, Atopic (Phase 3)
Dermatology (Phase 2)
Dermatomyositis (Early Phase 1)
Diabetes Mellitus (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Foot (Phase 1/Phase 2)
Diabetic Nephropathies (Early Phase 1)
Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)
Endothelial Cells (Phase 1/Phase 2)
End Stage Liver Disease (Phase 1/Phase 2)
Epidermolysis Bullosa (Phase 1/Phase 2)
Erectile Dysfunction (Phase 1)
Erythropoietin (Phase 1/Phase 2)
Eye Diseases (Phase 1)
Eye Neoplasms (Phase 1)
Fetal Blood (Phase 1/Phase 2)
Fractures, Bone (Phase 3)
Frailty (Phase 1/Phase 2)
General Surgery (Phase 1)
Graft vs Host Disease (Phase 3)
Heart Diseases (Phase 1/Phase 2)
Heart Failure (Phase 2)
Heart Failure, Systolic (Phase 1/Phase 2)
Heel (Phase 1)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 1/Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemorrhage (Phase 1/Phase 2)
Hepatitis, Autoimmune (Phase 1/Phase 2)
Hepatitis B (Phase 1/Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1)
Infant, Extremely Premature (Phase 1)
Infant, Premature (Phase 2/Phase 3)
Infarction, Anterior Cerebral Artery (Phase 1/Phase 2)
Infarction, Middle Cerebral Artery (Phase 1/Phase 2)
Infarction, Posterior Cerebral Artery (Phase 1/Phase 2)
Infections (Phase 2)
Infertility, Female (Phase 1)
Inflammation (Phase 2)
Ischemia (Phase 2/Phase 3)
Ischemic Stroke (Phase 2/Phase 3)
Keloid (Phase 4)
Kidney Diseases (Phase 2)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Liver Cirrhosis (Phase 2)
Liver Cirrhosis, Alcoholic (Phase 1)
Liver Cirrhosis, Biliary (Phase 1/Phase 2)
Liver Failure (Phase 2)
Liver Transplantation (Phase 1)
Lung Injury (Phase 1/Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 3)
Machado-Joseph Disease (Phase 2)
Meniscus (Phase 1)
Mesenchymal Stem Cells (Phase 3)
Metabolic Syndrome (Phase 1/Phase 2)
Multiple Organ Failure (Phase 1/Phase 2)
Multiple Sclerosis (Phase 1/Phase 2)
Muscular Dystrophy, Duchenne (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myocardial Infarction (Phase 1/Phase 2)
Myocardial Ischemia (Phase 2)
Nasal Septal Perforation (Phase 1/Phase 2)
Neoplasms (Early Phase 1)
Neuromyelitis Optica (Phase 1/Phase 2)
Neutropenia (Phase 1/Phase 2)
Organ Transplantation (Phase 1/Phase 2)
Osteoarthritis (Phase 3)
Osteoarthritis, Knee (Phase 2)
Osteonecrosis (Phase 1/Phase 2)
Pain (Phase 1)
Parkinson Disease (Phase 1/Phase 2)
Pathologic Processes (Phase 2)
Peripheral Arterial Disease (Phase 1/Phase 2)
Peripheral Vascular Diseases (Phase 1)
Pharmacokinetics (Phase 1/Phase 2)
Pneumoconiosis (Phase 1)
Pneumonia (Phase 1/Phase 2)
Pneumonia, Ventilator-Associated (Phase 2)
Pneumonia, Viral (Phase 2)
Poisoning (Phase 1/Phase 2)
Polycystic Ovary Syndrome (Phase 1/Phase 2)
Polymyositis (Early Phase 1)
Primary Ovarian Insufficiency (Phase 2)
Psoriasis (Phase 1/Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Radiology (Phase 1/Phase 2)
Radiotherapy (Phase 1)
Rectal Fistula (Phase 1/Phase 2)
Renal Insufficiency, Chronic (Phase 1/Phase 2)
Respiratory Distress Syndrome (Phase 2)
Retinitis Pigmentosa (Phase 2/Phase 3)
Rhinitis, Allergic (Phase 1)
Rhytidoplasty (Phase 1)
Safety (Phase 1/Phase 2)
Sclera (Phase 2)
Scleroderma, Systemic (Phase 1/Phase 2)
Sepsis (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Sexual Dysfunction, Physiological (Phase 1/Phase 2)
Shock (Phase 2)
Shock, Septic (Phase 2)
Spinal Cord Injuries (Phase 2)
Spinocerebellar Ataxias (Phase 2)
Spinocerebellar Degenerations (Phase 1/Phase 2)
Spondylitis, Ankylosing (Phase 1)
ST Elevation Myocardial Infarction (Phase 3)
Stem Cells (Phase 4)
Stroke (Phase 2)
Sweat Gland Diseases (Phase 1)
Systemic Inflammatory Response Syndrome (Phase 2)
Talus (Phase 3)
Thrombocytopenia (Phase 1/Phase 2)
Traumatology (Phase 2)
Treatment Outcome (Phase 1/Phase 2)
Umbilical Cord (Phase 1/Phase 2)
Uterus (Phase 2)
Ventricular Dysfunction, Left (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue